ir. Fjoralba Zeka

Journal Article
A2
open access

Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation

Alan Van Goethem (UGent) , Jill Deleu (UGent) , Nurten Yigit (UGent) , Celine Everaert (UGent) , Myrthala Moreno-Smith, Sanjeev A Vasudevan, Fjoralba Zeka (UGent) , Fleur Demuynck (UGent) , Eveline Barbieri, Franki Speleman (UGent) , et al.

(2023) NAR CANCER. 5(1).

Add to list

Circulating microRNA biomarkers for metastatic neuroblastoma

Fjoralba Zeka (UGent) , Alan Van Goethem (UGent) , Tim Lammens (UGent) , Anneleen Decock (UGent) , Hetty Helsmoortel (UGent) , Genevieve Laureys (UGent) , Michael Hogarty, Eveline Barbieri, Jason Shohet, Frank Berthold, et al.

(2018) Advances in Neuroblastoma Research, Congress abstracts.

Add to list

Longitudinal evaluation of murine serum microRNAs as biomarkers for neuroblastoma burden and therapeutic TP53 reactivation

Alan Van Goethem (UGent) , Nurten Yigit (UGent) , Celine Everaert (UGent) , Myrthala Moreno-Smith, Sanjeev A Vasudevan, Fjoralba Zeka (UGent) , Fleur Demunck, Eveline Barbieri, Franki Speleman (UGent) , Pieter Mestdagh (UGent) , et al.

(2018) Advances in Neuroblastoma Research, Congress abstracts.

Add to list

Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients

Fjoralba Zeka (UGent) , Anneleen Decock (UGent) , Alan Van Goethem (UGent) , Katrien Vanderheyden, Fleur Demuynck (UGent) , Tim Lammens (UGent) , Hetty Helsmoortel (UGent) , Joëlle Vermeulen, Rosa Noguera, Ana P. Berbegall, et al.

(2018) JCI INSIGHT. 3(23).

Add to list

PhD Thesis

Assessment of risk refinement strategies for improved clinical outcome of neuroblastoma patients

Fjoralba Zeka (UGent)

(2018)

Add to list

Journal Article
A1
open access

Straightforward and sensitive RT-qPCR based gene expression analysis of FFPE samples

Fjoralba Zeka (UGent) , Katrien Vanderheyden, Els De Smet (UGent) , Claude Cuvelier (UGent) , Pieter Mestdagh (UGent) and Jo Vandesompele (UGent)

(2016) SCIENTIFIC REPORTS. 6.

Add to list

Book Chapter

RT-qPCR-based quantification of small non-coding RNAs

Fjoralba Zeka (UGent) , Pieter Mestdagh (UGent) and Jo Vandesompele (UGent)

(2015) Small non-coding RNAs : methods and protocols. In Methods in Molecular Biology 1296. p.85-102

Add to list

CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients

Ali Rihani (UGent) , Bram De Wilde (UGent) , Fjoralba Zeka (UGent) , Genevieve Laureys (UGent) , Nadine Francotte, Gian Paolo Tonini, Simona Coco, Rogier Versteeg, Rosa Noguera, Johannes Schulte, et al.

(2014) OncoPoint, 2nd Meeting, Abstracts.

Add to list

CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients

Ali Rihani (UGent) , Bram De Wilde (UGent) , Fjoralba Zeka (UGent) , Genevieve Laureys (UGent) , Nadine Francotte, Gian Paolo Tonini, Simona Coco, Rogier Versteeg, Rosa Noguera, Johannes Schulte, et al.

(2014) Translational genetics : from cage over bench to bed.

Add to list

Targeted analysis of TP53 pathway SNPs in neuroblastoma patients

Ali Rihani (UGent) , Bram De Wilde (UGent) , Fjoralba Zeka (UGent) , Genevieve Laureys (UGent) , Nadine Francotte, Gian Paolo Tonini, Simona Coco, Rogier Versteeg, Rosa Noguera, Johannes Schulte, et al.

(2014) ANR Cologne 2014 : information book.

Academic Bibliography

ir. Fjoralba Zeka

Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation

Circulating microRNA biomarkers for metastatic neuroblastoma

Longitudinal evaluation of murine serum microRNAs as biomarkers for neuroblastoma burden and therapeutic TP53 reactivation

Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients

Assessment of risk refinement strategies for improved clinical outcome of neuroblastoma patients

Straightforward and sensitive RT-qPCR based gene expression analysis of FFPE samples

RT-qPCR-based quantification of small non-coding RNAs

CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients

CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients

Targeted analysis of TP53 pathway SNPs in neuroblastoma patients

Contents

Support

Contact